Status:
NOT_YET_RECRUITING
Targeted Approach to Prevent Early Obesity
Lead Sponsor:
Azienda Ospedaliera Universitaria Integrata Verona
Conditions:
Obesity, Pediatric
Eligibility:
All Genders
Up to 5 years
Phase:
NA
Brief Summary
Lead: UNIVR, Partners involved: UNIME, CHU Lille, INSERM-Lille This is a multi-center (UNIVR, UNIME, CHU Lille) randomized controlled trial aiming at evaluating the effect of a selective intervention...
Eligibility Criteria
Inclusion
- New-borns
- Parent/Guardian's informed consent
Exclusion
- Severe prematurity or congenital disease or anomaly or perinatal complication likely to imply long-term consequences on the child possibility to be fed and to grow physiologically (COBRISC is intended to be used to predict childhood obesity in healthy infants and the TAPE-Obesity trial does not provide specific programmes for children with impaired capacity to thrive physiologically)
- Family unavailability to plan a regular follow-up at the local Paediatric Obesity Centre
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2028
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06177756
Start Date
May 1 2024
End Date
May 1 2028
Last Update
December 20 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.